Based on the knowledge that ceramides influence the immune response in the tumor microenvironment, combining nanoliposome C6-ceramide with the anti-CTLA4 antibody have shown improved anti-tumor immunity in hepatocellular cancer [105]. The gene discussed is CTLA4; the disease is neoplasm.